安琪酵母(600298.SH):董事會審議通過赴雲南普洱設立子公司議案
格隆匯 6 月 23日丨安琪酵母(600298.SH)公佈,公司第八屆董事會第十次會議召開,審議通過關於赴雲南普洱設立子公司議案;
2020年5月18日,公司召開第八屆董事會第九次會議審議通過了《關於赴雲南普洱設立子公司建設年產2.5萬噸酵母生產線項目一期的議案》,同意公司赴雲南普洱市瀾滄縣設立子公司,投資建設年產2.5萬噸酵母生產線項目一期(以下簡稱:普洱項目),該議案尚需提交股東大會批准後實施。現為穩妥、有序、規範推進普洱項目內外審批,完成項目施工前的各項籌備工作,公司決定前期先赴雲南普洱瀾滄縣設立子公司,開展相關具體工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.